Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise

Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexivel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug development research 1992, Vol.27 (2), p.89-106
Hauptverfasser: Billman, George E., Halliwill, John R., Avendano, Christopher E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 2
container_start_page 89
container_title Drug development research
container_volume 27
creator Billman, George E.
Halliwill, John R.
Avendano, Christopher E.
description Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ddr.430270203
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16816287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16816287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</originalsourceid><addsrcrecordid>eNp9kE1PGzEQhq2qSKTAkbsPVW9Lxx9ZO8eWj1AVgYQoHK1Z7xi23XhTewPh39dVoogTJ2vsZ17PPIwdCzgRAPJr26YTrUAakKA-sImAma2knM0-skm5lZVWM7HPPuX8G0AIbe2EufMQyI98CNxj77vVgvsnjJF6jnHExyF2ecx8iHx8ooKktkPPn_ERez4OkXiivBxiplLxvGoWuO4W5Y3WlHyX6ZDtBewzHW3PA_br4vzu9LK6upn_OP12VXllhapUkMYrbLXVlhrfKGqsbEIt9RTAIAUINUoKKFshodVgqKHa1F5DSyRIHbAvm9xlGv6uKI9u0WVPfY-RhlV2orailtYUsNqAPg05JwpumcrE6dUJcP81uqLR7TQW_vM2GHMxFBLGsteuSSszFdO6YGaDvXQ9vb6f6c7Obt9-sB2oiKb1rhPTH1ebku4erufu-ifcf7-8m7sH9Q_iGJOD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16816287</pqid></control><display><type>article</type><title>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Billman, George E. ; Halliwill, John R. ; Avendano, Christopher E.</creator><creatorcontrib>Billman, George E. ; Halliwill, John R. ; Avendano, Christopher E.</creatorcontrib><description>Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.</description><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>DOI: 10.1002/ddr.430270203</identifier><identifier>CODEN: DDREDK</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Cardiovascular system ; heart rate variability ; Medical sciences ; Miscellaneous ; parasympathetic activity ; Pharmacology. Drug treatments ; time-series analysis</subject><ispartof>Drug development research, 1992, Vol.27 (2), p.89-106</ispartof><rights>Copyright © 1992 Wiley‐Liss, Inc.</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</citedby><cites>FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fddr.430270203$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fddr.430270203$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4375156$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Billman, George E.</creatorcontrib><creatorcontrib>Halliwill, John R.</creatorcontrib><creatorcontrib>Avendano, Christopher E.</creatorcontrib><title>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</title><title>Drug development research</title><addtitle>Drug Dev. Res</addtitle><description>Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>heart rate variability</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>parasympathetic activity</subject><subject>Pharmacology. Drug treatments</subject><subject>time-series analysis</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PGzEQhq2qSKTAkbsPVW9Lxx9ZO8eWj1AVgYQoHK1Z7xi23XhTewPh39dVoogTJ2vsZ17PPIwdCzgRAPJr26YTrUAakKA-sImAma2knM0-skm5lZVWM7HPPuX8G0AIbe2EufMQyI98CNxj77vVgvsnjJF6jnHExyF2ecx8iHx8ooKktkPPn_ERez4OkXiivBxiplLxvGoWuO4W5Y3WlHyX6ZDtBewzHW3PA_br4vzu9LK6upn_OP12VXllhapUkMYrbLXVlhrfKGqsbEIt9RTAIAUINUoKKFshodVgqKHa1F5DSyRIHbAvm9xlGv6uKI9u0WVPfY-RhlV2orailtYUsNqAPg05JwpumcrE6dUJcP81uqLR7TQW_vM2GHMxFBLGsteuSSszFdO6YGaDvXQ9vb6f6c7Obt9-sB2oiKb1rhPTH1ebku4erufu-ifcf7-8m7sH9Q_iGJOD</recordid><startdate>1992</startdate><enddate>1992</enddate><creator>Billman, George E.</creator><creator>Halliwill, John R.</creator><creator>Avendano, Christopher E.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope></search><sort><creationdate>1992</creationdate><title>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</title><author>Billman, George E. ; Halliwill, John R. ; Avendano, Christopher E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>heart rate variability</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>parasympathetic activity</topic><topic>Pharmacology. Drug treatments</topic><topic>time-series analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Billman, George E.</creatorcontrib><creatorcontrib>Halliwill, John R.</creatorcontrib><creatorcontrib>Avendano, Christopher E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Billman, George E.</au><au>Halliwill, John R.</au><au>Avendano, Christopher E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</atitle><jtitle>Drug development research</jtitle><addtitle>Drug Dev. Res</addtitle><date>1992</date><risdate>1992</risdate><volume>27</volume><issue>2</issue><spage>89</spage><epage>106</epage><pages>89-106</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><coden>DDREDK</coden><abstract>Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/ddr.430270203</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-4391
ispartof Drug development research, 1992, Vol.27 (2), p.89-106
issn 0272-4391
1098-2299
language eng
recordid cdi_proquest_miscellaneous_16816287
source Wiley Online Library Journals Frontfile Complete
subjects Biological and medical sciences
Cardiovascular system
heart rate variability
Medical sciences
Miscellaneous
parasympathetic activity
Pharmacology. Drug treatments
time-series analysis
title Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T12%3A13%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20calcium%20channel%20antagonists%20on%20the%20cardiac%20vagal%20tone%20response%20to%20submaximal%20exercise&rft.jtitle=Drug%20development%20research&rft.au=Billman,%20George%20E.&rft.date=1992&rft.volume=27&rft.issue=2&rft.spage=89&rft.epage=106&rft.pages=89-106&rft.issn=0272-4391&rft.eissn=1098-2299&rft.coden=DDREDK&rft_id=info:doi/10.1002/ddr.430270203&rft_dat=%3Cproquest_cross%3E16816287%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16816287&rft_id=info:pmid/&rfr_iscdi=true